Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID‐19

por Pfeifer, Nathan D., Lo, Arthur, Bourdet, David L., Colley, Kenneth, Singh, Dave
Publicado 2021

An Experimental Approach To Evaluate the Impact of Impaired Transport Function on Hepatobiliary Drug Disposition Using Mrp2-Deficient TR(–) Rat Sandwich-Cultured Hepatocytes in Com...

por Yang, Kyunghee, Pfeifer, Nathan D., Hardwick, Rhiannon N., Yue, Wei, Stewart, Paul W., Brouwer, Kim L. R.
Publicado 2014

Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

por Burmester, Gerd R, Landewé, Robert, Genovese, Mark C, Friedman, Alan W, Pfeifer, Nathan D, Varothai, Nupun A, Lacerda, Ana P
Publicado 2017

Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial

por Belperio, John, Nguyen, Tuan, Lombardi, David A, Bogus, Maxim, Moskalenko, Valentyn, Singh, Dave, Haumann, Brett, Bourdet, David L, Kaufman, Elad, Pfeifer, Nathan D, Thompson, Corbin G, Woo, Jacky, Moran, Edmund J, Saggar, Rajeev
Publicado 2023

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19

por Singh, Dave, Bogus, Maxim, Moskalenko, Valentyn, Lord, Robert, Moran, Edmund J., Crater, Glenn D., Bourdet, David L., Pfeifer, Nathan D., Woo, Jacky, Kaufman, Elad, Lombardi, David A., Weng, Emily Y., Nguyen, Tuan, Woodcock, Ashley, Haumann, Brett, Saggar, Rajeev
Publicado 2021